US Backs Twice-Yearly HIV Injection for 271K Zimbabweans
A revolutionary HIV prevention shot that only requires two doses per year is coming to 271,000 people in Zimbabwe, backed by US support that could prevent more than 9,000 new infections. The groundbreaking injection removes daily pill barriers and offers a new path toward an AIDS-free generation.
Zimbabwe just launched a medical breakthrough that could change the lives of hundreds of thousands of people living with or at risk for HIV.
The United States announced Thursday it will support access to lenacapavir, a twice-yearly HIV prevention injection, for 271,000 Zimbabweans over the next three years. The programme aims to prevent more than 9,000 new HIV infections during that period.
The announcement took place in Epworth at the national launch of the injection, developed by US pharmaceutical company Gilead Sciences. Unlike daily pills, lenacapavir requires just two shots per year, making it far easier for people to stay protected.
US Deputy Chief of Mission Phillip Nervig called the drug a significant step forward in prevention efforts. "I am confident that as the Government of Zimbabwe takes even more leadership, an AIDS-free generation is within our reach," he said.
US Ambassador Pamela Tremont visited Epworth Overspill Clinic, one of the first facilities offering the injection. She highlighted how the new option addresses major barriers people face with daily medication, particularly around convenience and privacy.
The injection is already being used in the United States, Zambia, and Eswatini. Now Zimbabwe joins the expanding list of countries benefiting from this prevention science advancement.
The Ripple Effect
Zimbabwe has made real progress reducing HIV infections in recent years, but reaching vulnerable populations remains challenging. This new injection could transform prevention efforts by making it easier for people to stay protected without the daily reminder or stigma of pills.
The US has shifted its approach from simply providing aid to working directly with communities to build self-reliance. Ambassador Tremont emphasized this partnership approach, noting that together they're fighting HIV while building a stronger, more resilient health system for Zimbabwe's future.
Washington plans to expand access to the injection nationwide as part of broader efforts to strengthen Zimbabwe's entire health infrastructure. The programme represents both immediate protection for hundreds of thousands of people and a foundation for long-term health system improvements.
For people who struggled with daily medication schedules or worried about privacy, this twice-yearly option removes major obstacles to prevention. That accessibility could be the difference between infection and protection for thousands of Zimbabweans.
Zimbabwe's progress shows what's possible when innovation meets partnership and commitment to end AIDS for good.
Based on reporting by AllAfrica - Health
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it
